Ge Healthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty approved drugs.
There are three US patents protecting GE HEALTHCARE drugs.
There are seventy-two patent family members on GE HEALTHCARE drugs in twenty-five countries and one hundred and forty-seven supplementary protection certificates in eighteen countries.
Summary for Ge Healthcare
| International Patents: | 72 |
| US Patents: | 3 |
| Tradenames: | 57 |
| Ingredients: | 39 |
| NDAs: | 50 |
| Drug Master File Entries: | 5 |
| Patent Litigation for Ge Healthcare: | See patent lawsuits for Ge Healthcare |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 140 | iohexol | INJECTABLE;INJECTION | 018956-005 | Nov 30, 1988 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | TECHNETIUM TC 99M DIPHOSPHONATE-TIN KIT | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017562-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | AMIPAQUE | metrizamide | INJECTABLE;INJECTION | 017982-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | TECHNETIUM TC 99M MPI MDP | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018141-002 | Jun 12, 1989 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | MPI STANNOUS DIPHOSPHONATE | technetium tc-99m etidronate kit | INJECTABLE;INJECTION | 017667-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Ge Healthcare | MPI DMSA KIDNEY REAGENT | technetium tc-99m succimer kit | INJECTABLE;INJECTION | 017944-001 | May 18, 1982 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,021,481 | ⤷ Subscribe |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020351-002 | Mar 22, 1996 | 4,396,597 | ⤷ Subscribe |
| Ge Healthcare | OMNIPAQUE 240 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-002 | Dec 26, 1985 | 4,250,113 | ⤷ Subscribe |
| Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | 4,396,597 | ⤷ Subscribe |
| Ge Healthcare | VISIPAQUE 270 | iodixanol | INJECTABLE;INJECTION | 020351-001 | Mar 22, 1996 | RE36418 | ⤷ Subscribe |
| Ge Healthcare | ISOPAQUE 440 | calcium metrizoate; meglumine metrizoate; metrizoate magnesium; metrizoate sodium | INJECTABLE;INJECTION | 016847-001 | Approved Prior to Jan 1, 1982 | 3,476,802 | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2264018 | ⤷ Subscribe |
| Hong Kong | 1146725 | ⤷ Subscribe |
| Brazil | 0113470 | ⤷ Subscribe |
| Japan | 2010536931 | ⤷ Subscribe |
| Denmark | 2264018 | ⤷ Subscribe |
| Hong Kong | 1086270 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2203431 | CA 2015 00014 | Denmark | ⤷ Subscribe | PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115 |
| 2365988 | 2018C/006 | Belgium | ⤷ Subscribe | PRODUCT NAME: PATIROMER SORBITEX CALCIUM OF EERDER WELK ZOUT OF AFGELEIDE ERVAN; AUTHORISATION NUMBER AND DATE: EU/1/17/1179 20170721 |
| 0108638 | 97C0101 | Belgium | ⤷ Subscribe | PRODUCT NAME: IODIXANOL; NAT. REGISTRATION NO/DATE: 914 IS 204 F 12 19970325; FIRST REGISTRATION: SE 11758 19930205 |
| 3141251 | SPC/GB20/075 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: A MEDICINAL PRODUCT CONSISTING OF A COMBINATION OF A FIRST DOSE PHARMACEUTICAL COMPOSITION AND A SECOND DOSE PHARMACEUTICAL COMPOSITION, THE FIRST DOSE PHARMACEUTICAL COMPOSITION CONSISTING OF THE ACTIVE INGREDIENTS: POLYETHYLENE GLYCOL 3350, SODIUM SULPH; REGISTERED: IS IS/1/17/063/01 20171016; UK PL 20011/0040 20171016 |
| 0290047 | SPC/GB97/078 | United Kingdom | ⤷ Subscribe | PRODUCT NAME: MANGAFODIPIR AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, IN PARTICULAR MANGAFODIPIR TRISODIUM; REGISTERED: UK EU/1/97/040/001 19970522; UK EU/1/97/040/002 19970522 |
| 0480717 | 98C0022 | France | ⤷ Subscribe | PRODUCT NAME: MONTELUKAST SODIUM; REGISTRATION NO/DATE IN FRANCE: NL 23 133 DU 19980320; REGISTRATION NO/DATE AT EEC: 13 651 DU 19970825 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
